企業プロフィール
PerkinElmer 株価・ニュース・カタリスト
- ティッカー:
- RVTY
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
149.06 USD (-2.51%)
終値
最終更新: 2026年10月1日
11.2B USD
時価総額
株価変動の要因
2026年10月1日 時点で RVTY は 2.51% 下落し、$149.06 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Health Science Tools and Diagnostics Company
Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations.
Life Sciences Research Tools
The company offers imaging, detection, screening, automation, reagents, and assay technologies used in drug discovery and translational research. These tools help researchers study cells, proteins, genes, and disease mechanisms at multiple scales.
Translational Multi-Omics
Revvity's multi-omics capabilities combine genomic, transcriptomic, proteomic, and cellular analysis. The portfolio supports biomarker identification, target validation, and patient stratification across research and therapeutic-development workflows.
Diagnostics Portfolio
The diagnostics business supplies technologies for reproductive health, newborn screening, infectious disease, autoimmune testing, and other clinical applications. Instruments, assays, and laboratory software create recurring demand from regulated testing workflows.
Informatics and Workflow Integration
Revvity integrates laboratory informatics, data management, and analytics with its instruments and assays. This approach is intended to connect experimental data, automate interpretation, and improve continuity from discovery research to clinical use.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。